logo


SEQUENOM Announces August 6 Webcast of Financial and Other Business Results
Thursday, July 30, 2009 2:00 PM


San Diego, July 30 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM), will report second quarter 2009 and year-to-date financial results after market close on Thursday, August 6, 2009. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

    Conference Call Information:
    Domestic callers: 1-800-706-7749
    International callers: +1-617-614-3474
    Passcode: 42079558

Webcast information: Visit http://ir.sequenom.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

A webcast replay will be available on the SEQUENOM Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-888-286-8010 for domestic callers, or +1-617-801-6888 for international callers, and entering reservation code 47416001.

About SEQUENOM

SEQUENOM is a life sciences company committed to providing the best genetic analysis products that translate the results of genomic science into solutions for molecular diagnostics, biomedical research, translational research and molecular medicine applications. As an industry innovator in DNA detection technology, SEQUENOM's MassARRAY((R)) system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantification. On the diagnostics front, SEQUENOM is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the company's SEQureDx(TM) technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample. The company is also developing tests for oncology, infectious diseases and other disorders. The company was founded in 1994 and is headquartered in San Diego, California. For more information please visit http://www.sequenom.com.

SEQUENOM((R)), SEQureDx(TM), and MassARRAY((R)) are trademarks of SEQUENOM, Inc. All other trademarks and service marks are the property of their respective owners.

    Company Contact      Investor Relations Contact     Media Relations
    Ian Clements, PhD    Lippert/Heilshorn &            Pure Communications
                          Associates
    Sr. Director, Corp.  Jody Cain (jcain@lhai.com)     Sheryl Seapy
     Communications
    +1 (858) 202-9000    +1 (310) 691-7100              +1 (949) 608-0841

SOURCE SEQUENOM, Inc.

(Source: PR Newswire )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia